Pioneering cancer management
Coherence is a medical technology company working at the intersection of neurotechnology, neurobiology, and machine learning. Our mission is to improve quality and length of life for people with cancer.
Our vision
For decades, cancer treatment has remained largely unchanged — we cut it, we burn it, we poison it. These methods, while in some ways effective, come at a tremendous cost to the patient’s health, quality of life, and emotional well-being.
At Coherence, we believe there’s a better way. We are leading a revolution in cancer treatment, transforming it from a brutal battle into a precisely managed condition. By harnessing cutting-edge technology and groundbreaking research, we are shifting the paradigm.
The future we’re building now
Imagine a world where, from the moment cancer is detected, it is continuously monitored and precisely treated 24/7. A world where...
The likelihood of cancer spreading to other organs — the main reason it becomes terminal — is dramatically reduced.
You no longer have to endure debilitating chemotherapy, radiation, or aggressive surgeries that harm your healthy cells.
You can recover in the comfort of your home, rather than spending weeks in the hospital.
Your treatment adapts in real time, ensuring the best possible outcome with the fewest side effects.
This future isn’t decades away. It’s within reach; we’re bringing it to life.
Research
Technology that transforms lives
SOMA is the first in a suite of platforms designed to bring cancer into stasis while dramatically improving quality of life. Our platforms have applications across the human body.
The science of change
Our products decode the body's electrical signals in real time and deliver adaptive, precisely tuned stimulation to modulate biological activity and influence the course of disease. We leverage our expertise in neurobiology, our patented digital neural interfaces, and our AI-enabled data backend to design and build BCIs for cancer management.
